Skip to content
value.today
ViewRay, Inc. logo

ViewRay, Inc.

Formerly Mirax Corp.

Total raised
$69 M
4 rounds on record
Latest round
$26 M
Jan 2017
First round on record
Jul 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ViewRay, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2017$26 MNo. 4$10 to $50 million

ViewRay, Inc.: Raise no. 4, Jan 2017

Investors in this round

12 investors had bought by the notice of Feb 3, 2017: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ViewRay, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$26 M of $26 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ajay A. Bansal · Executive Officer
  • Chris A. Raanes · Executive Officer, Director
  • Douglas H. Keare · Executive Officer
  • James F. Dempsey · Executive Officer, Director
  • Michael S. Cogswell · Executive Officer
  • Aditya S. Puri · Director
  • Brian K. Roberts · Director
  • Caley H. Castelein · Director
  • David S. Bonita · Director
  • Henry A. McKinnell, Jr. · Director
  • Joshua S. Bilenker · Director
  • Mark S. Gold · Director
  • Theodore T. Wang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ajay Bansal, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 3, 2017. Read the notice at the SEC.

equity, optionsSEC
Aug 2016$14 MNo. 3$10 to $50 million

ViewRay, Inc.: Raise no. 3, Aug 2016

Investors in this round

12 investors had bought by the notice of Sep 9, 2016: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ViewRay, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ajay A. Bansal · Executive Officer
  • Chris A. Raanes · Executive Officer, Director
  • Douglas H. Keare · Executive Officer
  • James F. Dempsey · Executive Officer, Director
  • Michael S. Cogswell · Executive Officer
  • Aditya S. Puri · Director
  • Brian K. Roberts · Director
  • Caley H. Castelein · Director
  • David S. Bonita · Director
  • Henry A. McKinnell, Jr. · Director
  • Joshua S. Bilenker · Director
  • Mark S. Gold · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ajay Bansal, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 9, 2016. Read the notice at the SEC.

equity, optionsSEC
Aug 2015$3 MNo. 2$2 to $10 million

ViewRay, Inc.: Raise no. 2, Aug 2015

Investors in this round

60 investors had bought by the notice of Aug 28, 2015: 60 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ViewRay, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$217,520
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris A. Raanes · Executive Officer, Director
  • D. David A. Chandler · Executive Officer
  • James F. Dempsey · Executive Officer, Director
  • Michael F. Brandt · Executive Officer
  • Aditya S. Puri · Director
  • Caley F. Castelein · Director
  • David S. Bonita · Director
  • Joshua S. Bilenker · Director
  • Mark S. Gold · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • MLV & Co. LLC (CRD 150959) · broker-dealer MLV & Co. LLC (CRD 150959) · New York, New YorkSold in AL, AR, CA, FL, MD, MI, NY, OH, TX, VA
  • American Portfolios Financial Services, Inc. (CRD 18487) · broker-dealer American Portfolios Financial Services, Inc. (CRD 18487) · Holbrook, New YorkSold in GA, IL, MN, NC, NY, PA
  • Dinosaur Securities LLC (CRD 104446) · broker-dealer Dinosaur Securities LLC (CRD 104446) · New York, New YorkSold in CA, CT, NJ
  • Katalyst Securities LLC (CRD 112494) · broker-dealer Katalyst Securities LLC (CRD 112494) · New York, New YorkSold in CA, CO, CT, FL, GA, IL, IN, KS, MA, NY, PA, TX, and outside the US

Signed by James F. Dempsey, Corporate Secretary. Source: SEC Form D, newest notice filed Aug 28, 2015. Read the notice at the SEC.

equitySEC
Jul 2015$27 MNo. 1$10 to $50 million

ViewRay, Inc.: Raise no. 1, Jul 2015

Investors in this round

115 investors had bought by the notice of Aug 7, 2015: 115 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ViewRay, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$27 M of $27 M offered
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$951,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Chris A. Raanes · Executive Officer, Director
  • D. David A. Chandler · Executive Officer
  • James F. Dempsey · Executive Officer, Director
  • Michael F. Brandt · Executive Officer
  • Aditya S. Puri · Director
  • Caley F. Castelein · Director
  • David S. Bonita · Director
  • Joshua S. Bilenker · Director
  • Mark S. Gold · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • American Portfolios Financial Services, Inc. (CRD 18487) · broker-dealer American Portfolios Financial Services, Inc. (CRD 18487) · Holbrook, New YorkSold in CA, CO, CT, FL, IA, IL, IN, KY, MI, NJ, NM, NV, NY, TX
  • Northland Securities, Inc. (CRD 40258) · broker-dealer Northland Securities, Inc. (CRD 40258) · Minneapolis, MinnesotaSold in TX, and outside the US
  • Katalyst Securities LLC (CRD 112494) · broker-dealer Katalyst Securities LLC (CRD 112494) · New York, New YorkSold in AL, AZ, CA, CO, CT, FL, IL, IN, MA, MD, NJ, NY, OH, PA, TX, VA, WA, and outside the US
  • Trout Capital LLC (CRD 131489) · broker-dealer Trout Capital LLC (CRD 131489) · New York, New YorkSold in TX
  • MLV & Co. LLC (CRD 150959) · broker-dealer MLV & Co. LLC (CRD 150959) · New York, New YorkSold in CA, LA, MA, OH, PA, TX
  • Dinosaur Securities LLC (CRD 104446) · broker-dealer Dinosaur Securities LLC (CRD 104446) · New York, New YorkSold in MA, NJ, NY

Remarks in the notice

  • On fees: “$951,000 consists of (1) approximately $776,000 in placement agent fees and (2) the $175,000 agreed-upon cap on placement agent expense reimbursement, the total for which has not yet been finalized.”

Signed by David Chandler, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 7, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ViewRay, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2017).

    SEC Form D · Feb 2017

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Feb 2017

That is all the official record says: ViewRay, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

In its own words

How the company describes itself to search engines on its website, word for word.

“MRIdian allows oncologists to visualize, adapt, and target using anatomical detail that is simply unavailable with conventional IGRT technologies.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

2 named in official filings. Open an investor to see everything it has backed.

Investors in ViewRay, Inc.
InvestorKindAmountRoundRoleSource
Fosun International LtdFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Strong Influence LtdCompanynot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 115 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ViewRay, Inc.
NameRoleNamed in
Ajay A. BansalExecutive officerFeb 2017
Chris A. RaanesExecutive officerFeb 2017
Douglas H. KeareExecutive officerFeb 2017
James F. DempseyExecutive officerFeb 2017
Michael S. CogswellExecutive officerFeb 2017
D. David A. ChandlerExecutive officerAug 2015
Michael F. BrandtExecutive officerAug 2015
Aditya S. PuriDirectorFeb 2017
Brian K. RobertsDirectorFeb 2017
Caley H. CasteleinDirectorFeb 2017
Chris A. RaanesDirectorFeb 2017
David S. BonitaDirectorFeb 2017
Henry A. McKinnell, Jr.DirectorFeb 2017
James F. DempseyDirectorFeb 2017
Joshua S. BilenkerDirectorFeb 2017
Mark S. GoldDirectorFeb 2017
Theodore T. WangDirectorFeb 2017
Caley F. CasteleinDirectorAug 2015

About

Medical technology company based in Cleveland, Ohio.